methamphetamine and luteolin

methamphetamine has been researched along with luteolin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, T; Li, L; Li, T; Liu, F; Liu, X; Sun, B; Yan, T; Yang, P1
Chen, LJ; Li, JH; Qu, D; Tan, XH; Wang, HJ; Wang, Q; Xie, XL; Xu, JT; Zhang, KK1

Other Studies

2 other study(ies) available for methamphetamine and luteolin

ArticleYear
Luteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in mice.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Animals; JNK Mitogen-Activated Protein Kinases; Luteolin; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Motor Activity; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Putamen; Signal Transduction

2014
Luteolin alleviates methamphetamine-induced neurotoxicity by suppressing PI3K/Akt pathway-modulated apoptosis and autophagy in rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 137

    Topics: Animals; Apoptosis; Autophagy; Gene Expression; Luteolin; Male; Methamphetamine; Neurotoxicity Syndromes; Phosphatidylinositol 3-Kinases; Principal Component Analysis; Protective Agents; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction

2020